Loading company…
Travanti Pharma developed microneedle devices for delivering medicines, vaccines, and topical products.
Travanti Pharma focused on microneedle drug delivery, including the AdminPen™ injector and AdminStamp devices using AdminPatch® technology. Its products were designed for medical and cosmetic applications. The company raised USD 7.50 mn in a Series B round from Prolog Ventures and Spring Bay Companies before being acquired by Teikoku Pharma USA in May 2009.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in